Introdução: A força muscular periférica e respiratória pode estar reduzida em pacientes com doença pulmonar obstrutiva crônica (DPOC). O impacto desta redução sobre a capacidade de realizar atividades e exercícios não é bem conhecida. Objetivos: Comparar a força muscular periférica e respiratória e o desempenho no teste da caminhada de 6 minutos (TC6) e no teste de senta e levanta de 1 minuto (TSL) em indivíduos com e sem DPOC e estudar o impacto da força muscular nos dois testes. Métodos: Foram estudados 21 pacientes com DPOC (13 homens, idade de 63±7 anos, volume expiratório forçado no primeiro segundo - VEF1 – 1,14±0,54, 42±18% do previsto) e 21 indivíduos sem DPOC (13 homens, idade 64±7 anos, VEF1 2,64±0,65, 106±21% do previsto). Todos os indivíduos realizaram espirometria, avaliação da pressão inspiratória máxima (PImáx) e expiratória máxima (PEmáx), teste de uma repetição máxima (1RM) para avaliar força do quadríceps, TC6 e TSL. Resultados: Quando comparados com controles pacientes com DPOC apresentaram valores inferiores de PImáx (77±23 cm H2O vs 102±18 cm H2O, p=0,0001), PEmáx (100±26 cm H2O vs 127±23 cm H2O, p=0,001), força do quadríceps (17±5 Kg vs 23±4 Kg, p=0,0001), distância no TC6 (405±76 m vs 539±48 m, p=0,0001) e repetições no TSL (25±6 vs 35±6, p=0,0001). No grupo de 42 indivíduos a distância percorrida no TC6 se associou com o VEF1 (r=0,80, p=0,0001), com a PImáx (r=0,59, p=0,0001), com a PEmáx (r=0,63, p=0,0001), com a SpO2 basal (r=0,61, p=0,0001) e com a força do quadríceps (r=0,63, p=0,0001). Num modelo multivariado o VEF1, a PImáx e a dispneia basal explicaram 81% da variabilidade da distância percorrida no TC6. Em relação ao TSL as melhores correlações foram observadas com o VEF1 (r=0,55, p=0,0001) e com a força do quadríceps (r=0,50, p=0,0001) e associação mais fraca foi observada com as pressões respiratórias máximas (r=0,34, p=0,02). A distância percorrida no TC6 se associou com o número de repetições no TSL (r=0,61, p=0,0001). Conclusões: Pacientes com DPOC tem redução da força muscular do quadríceps e das pressões respiratórias e um pior desempenho no TC6 e no TSL em relação aos controles. Tanto a força muscular do quadríceps como as pressões respiratórias influenciam o desempenho nos dois testes. Entretanto, o impacto da força do quadríceps sobre a distância percorrida parece depender do VEF1. Observamos uma relação forte entre a distância percorrida e o número de elevações no TST, sugerindo que o TST possa ter um papel na avaliação funcional de pacientes com DPOC. / Introduction: Peripheral and respiratory muscle strength may be reduced in patients with chronic obstructive pulmonary disease (COPD). The impact of this reduction on the ability to perform activities and exercises is not well known. Aims: To compare the peripheral and respiratory muscle strength and the performance in a 6-minute walk test (6MWT) and a sit-to-stand test (STST) in subjects with and without COPD and to study the impact of the muscle strength on both tests. Methods: We studied 21 patients with COPD (13 men, age 63±7 years, forced expiratory volume in one second, FEV1 1.14±0.54, 42 ± 18% predicted ) and 21 subjects without COPD (13 men, age 64±7 years, FEV1 2.64±0.65, 106±21% predicted). All subjects underwent spirometry, maximal inspiratory (MIP) and expiratory pressure (MEP), one-repetition maximum (1RM) to evaluate quadriceps strength, 6MWT and STST. Results: When compared to controls patients with COPD showed lower values of MIP (77±23 cm H2O vs. 102±18 cm H2O, p=0.0001), MEP (100±26 cm H2O vs 127±23 cm H2O, p=0.001), quadriceps strength (17 ± 5 kg vs. 23 ± 4 kg, p=0.0001), distance in 6MWT (405±76 m vs 539±48 m, p = 0.0001) and repetitions in STST (25±6 vs 35±6, p=0.0001). The walked distance was associated with FEV1 (r=0.80, p=0.0001), MIP (r=0.59, p=0.0001), MEP (r=0.63, p=0.0001), baseline SpO2 (r=0.61, p=0.0001) and quadriceps strength (r=0.63, p=0.0001). In a multivariate model FEV1, MIP and baseline dyspnea explained 81% of the walked distance variance in 6MWT. Regarding the TSL, the best correlations were observed with FEV1 (r=0.55, p=0.0001) and quadriceps strength (r=0.495, p = 0.0001) while a weaker association was observed with the maximal respiratory pressures (r=0.34, p=0.02). The distance walked in 6MWT was associated with the number of repetitions in TSL (r=0.61, p=0.0001). Conclusions: Patients with COPD have reduced quadriceps muscle strength and respiratory pressures and a worse performance in the 6MWT and STST in relation to controls. Both the quadriceps muscle strength and respiratory pressure influenced the performance in both tests. However, the impact of quadriceps strength on the walked distance seems to depend on FEV1. We observed a strong relationship between distance and number of elevations in STST, suggesting that STST may have a role in the functional evaluation of patients with COPD.

Introdução: A força muscular periférica e respiratória pode estar reduzida em pacientes com doença pulmonar obstrutiva crônica (DPOC). O impacto desta redução sobre a capacidade de realizar atividades e exercícios não é bem conhecida. Objetivos: Comparar a força muscular periférica e respiratória e o desempenho no teste da caminhada de 6 minutos (TC6) e no teste de senta e levanta de 1 minuto (TSL) em indivíduos com e sem DPOC e estudar o impacto da força muscular nos dois testes. Métodos: Foram estudados 21 pacientes com DPOC (13 homens, idade de 63±7 anos, volume expiratório forçado no primeiro segundo - VEF1 – 1,14±0,54, 42±18% do previsto) e 21 indivíduos sem DPOC (13 homens, idade 64±7 anos, VEF1 2,64±0,65, 106±21% do previsto). Todos os indivíduos realizaram espirometria, avaliação da pressão inspiratória máxima (PImáx) e expiratória máxima (PEmáx), teste de uma repetição máxima (1RM) para avaliar força do quadríceps, TC6 e TSL. Resultados: Quando comparados com controles pacientes com DPOC apresentaram valores inferiores de PImáx (77±23 cm H2O vs 102±18 cm H2O, p=0,0001), PEmáx (100±26 cm H2O vs 127±23 cm H2O, p=0,001), força do quadríceps (17±5 Kg vs 23±4 Kg, p=0,0001), distância no TC6 (405±76 m vs 539±48 m, p=0,0001) e repetições no TSL (25±6 vs 35±6, p=0,0001). No grupo de 42 indivíduos a distância percorrida no TC6 se associou com o VEF1 (r=0,80, p=0,0001), com a PImáx (r=0,59, p=0,0001), com a PEmáx (r=0,63, p=0,0001), com a SpO2 basal (r=0,61, p=0,0001) e com a força do quadríceps (r=0,63, p=0,0001). Num modelo multivariado o VEF1, a PImáx e a dispneia basal explicaram 81% da variabilidade da distância percorrida no TC6. Em relação ao TSL as melhores correlações foram observadas com o VEF1 (r=0,55, p=0,0001) e com a força do quadríceps (r=0,50, p=0,0001) e associação mais fraca foi observada com as pressões respiratórias máximas (r=0,34, p=0,02). A distância percorrida no TC6 se associou com o número de repetições no TSL (r=0,61, p=0,0001). Conclusões: Pacientes com DPOC tem redução da força muscular do quadríceps e das pressões respiratórias e um pior desempenho no TC6 e no TSL em relação aos controles. Tanto a força muscular do quadríceps como as pressões respiratórias influenciam o desempenho nos dois testes. Entretanto, o impacto da força do quadríceps sobre a distância percorrida parece depender do VEF1. Observamos uma relação forte entre a distância percorrida e o número de elevações no TST, sugerindo que o TST possa ter um papel na avaliação funcional de pacientes com DPOC. / Introduction: Peripheral and respiratory muscle strength may be reduced in patients with chronic obstructive pulmonary disease (COPD). The impact of this reduction on the ability to perform activities and exercises is not well known. Aims: To compare the peripheral and respiratory muscle strength and the performance in a 6-minute walk test (6MWT) and a sit-to-stand test (STST) in subjects with and without COPD and to study the impact of the muscle strength on both tests. Methods: We studied 21 patients with COPD (13 men, age 63±7 years, forced expiratory volume in one second, FEV1 1.14±0.54, 42 ± 18% predicted ) and 21 subjects without COPD (13 men, age 64±7 years, FEV1 2.64±0.65, 106±21% predicted). All subjects underwent spirometry, maximal inspiratory (MIP) and expiratory pressure (MEP), one-repetition maximum (1RM) to evaluate quadriceps strength, 6MWT and STST. Results: When compared to controls patients with COPD showed lower values of MIP (77±23 cm H2O vs. 102±18 cm H2O, p=0.0001), MEP (100±26 cm H2O vs 127±23 cm H2O, p=0.001), quadriceps strength (17 ± 5 kg vs. 23 ± 4 kg, p=0.0001), distance in 6MWT (405±76 m vs 539±48 m, p = 0.0001) and repetitions in STST (25±6 vs 35±6, p=0.0001). The walked distance was associated with FEV1 (r=0.80, p=0.0001), MIP (r=0.59, p=0.0001), MEP (r=0.63, p=0.0001), baseline SpO2 (r=0.61, p=0.0001) and quadriceps strength (r=0.63, p=0.0001). In a multivariate model FEV1, MIP and baseline dyspnea explained 81% of the walked distance variance in 6MWT. Regarding the TSL, the best correlations were observed with FEV1 (r=0.55, p=0.0001) and quadriceps strength (r=0.495, p = 0.0001) while a weaker association was observed with the maximal respiratory pressures (r=0.34, p=0.02). The distance walked in 6MWT was associated with the number of repetitions in TSL (r=0.61, p=0.0001). Conclusions: Patients with COPD have reduced quadriceps muscle strength and respiratory pressures and a worse performance in the 6MWT and STST in relation to controls. Both the quadriceps muscle strength and respiratory pressure influenced the performance in both tests. However, the impact of quadriceps strength on the walked distance seems to depend on FEV1. We observed a strong relationship between distance and number of elevations in STST, suggesting that STST may have a role in the functional evaluation of patients with COPD.

L’évaluation de la Distance de Marche Maximale (DMM) des artériopathes claudicants représente un enjeu primordial puisqu'une DMM inférieure à 300 mètres est en faveur d'une prise charge chirurgicale. En routine clinique, la DMM est évaluée par questionnaires, méthode d'évaluation très subjective, ou par tests de marche sur tapis roulant qui sont protocole-dépendants et reproduisent mal la douleur habituelle. Aussi, l'objet de cette thèse est de tester la validité de méthodologies innovantes utilisant le GPS et la mesure transcutanée de la pression en dioxygène (TcPO2) lors d’un test de marche sur tapis roulant à l’égard de l’évaluation de la gêne fonctionnelle à la marche de patients artériopathes claudicants. La première étude montre que les scores au questionnaire EACHQ et la DMM déclarée par les patients sont plus corrélés à la DMM mesurée avec un GPS (reflet du patron de marche spontané) qu'aux scores du questionnaire WIQ, au test de marche de 6 minutes et au test sur tapis roulant. La seconde étude montre l'intérêt de la TcPO2 d'effort dans la détection des ischémies à l’exercice chez des patients présentant des Index de Pression Systolique de Cheville normaux. Les troisième et quatrième études montrent la fiabilité du GPS ainsi que son applicabilité dans l'évolution des paramètres de marche avant et après une revascularisation. Enfin, la cinquième étude suggère que le couplage GPS-accéléromètre permet l’estimation indirecte de la dépense énergétique chez le patient artériopathe. En conclusion, l'actimétrie (e.g., GPS, accéléromètre) et laTcPO2 d’effort constituent des méthodes valides et fidèles pour évaluer la marche de patients artériopathes claudicants. / Peripheral Arterial Diseased (PAD) is a major concern regarding their clinical care since a revascularization intervention is indicated below the cut-off point of 300 m. In clinical routine, MWD is usually assessed with clinical questionnaires, a highly subjective method, and with walking treadmill tests that are design-dependent and that hardly reproduce the usual pain of the patients during the walk. Therefore, the aim of this doctoral work is to test the validity of innovative methodologies based on GPS and Transcutaneous Pressure in Oxygen (TcPO2) during a treadmill test with respect to the assessment of the functional limitation in PAD patients. The first study shows that scores of the Estimation of Ambulatory Capacity by History-Questionnaire and MWD that is declared by the patients are more related to the GPS-measured MWD (that reflects the spontaneous walking pattern) than to the scores of the Walking Impairment Questionnaire, the 6-min walking test, and the walking treadmill test. The second study evidences the relevance of the use of TcPO2 during a walking treadmill test in detecting ischemia during exercise among patients with normal Ankle to brachial Index. The third and fourth studies show the reliability of the GPS as well as its applicability to the evolvement of the walking parameters following revascularization. Finally, the fifth study suggests that the GPS-accelerometer coupling is able to estimate the energy expenditure of PAD patients. To conclude, actimetry (e.g., GPS, accelerometer) and exercise TcPO2 are valid and reliable methods to evaluate the walk of PAD patients.

Title: Effect of physical activity Nordic Walking on body composition and cardiorespiratory parameters in individuals after kidney transplantation and dialysis individual. Objective: The aim of the study was to determine the effect of physical activity Nordic Walking on body composition and cardiorespiratory parameters in individuals after kidney transplantation and dialysis individual. Method: This thesis has been prepared in the form of a qualitative case study. The study involved 9 probands at the beginning, but only 5 probands completed the study. It was done the input examination before the intervention. The intervention was made from 20 lessons of Nordic Walking which should take 60 minutes each of them. Then were probands tested again like the output examination. During these both examination were measured specific values of body composition, anthropometric values (height, weight, age, circuit level), as well as the distribution of muscle and fat mass in the body, the value of physical fitness, respectively. cardiorespiratory parameters of the individual, for which was used the spiroergometric test within a modified Balke's walking test. For to detect the quality of life was used before and after intervention standardized questionnaire assessing quality of life WHOQOL-BREF. Last but not...